Skip to main content
Equibles

UBS Group AG

Position in CBUS — Cibus, Inc.

CIK 1610520 ZURICH, V8
Back to CBUS Full portfolio

Position in CBUS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$67,541
-$43,775 QoQ
Shares Held
49,301
-12.3% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 62 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CBUS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. CBUS ranks #379 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in CBUS

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $67,541 49,301
2026-03-31 $111,316 56,221
2025-12-31 $25,553 14,686
2025-09-30 $16,558 12,837
2025-06-30 $182,426 132,194
2025-03-31 $37,762 20,194
2024-12-31 $110,700 39,821
2024-09-30 $50,415 15,465
2024-06-30 $125,154 12,706
2024-03-31 $182,509 8,126
2023-12-31 $183,672 9,352
2023-09-30 $147,946 8,120
2023-06-30 $4,084 389